{"id":"NCT04051710","sponsor":"Aurobindo Pharma Ltd","briefTitle":"Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH","officialTitle":"Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate Efficacy and Safety of Beclomethasone Dipropionate Metered Dose Inhaler (Inhalation Aerosol) (0.04mg/ INH) in Male and/ or Female Subjects With Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-03-12","primaryCompletion":"2019-08-29","completion":"2019-12-20","firstPosted":"2019-08-09","resultsPosted":"2020-11-13","lastUpdate":"2020-11-13"},"enrollment":1550,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Bronchial Asthma"],"interventions":[{"type":"DRUG","name":"Test Product","otherNames":["Test"]},{"type":"DRUG","name":"Reference Product","otherNames":["QVAR"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Group-I (Test)","type":"EXPERIMENTAL"},{"label":"Group-II (Reference)","type":"ACTIVE_COMPARATOR"},{"label":"Group-III (Placebo)","type":"PLACEBO_COMPARATOR"}],"summary":"To compare the therapeutic equivalence of Beclomethasone Dipropionate MDI (Inhalation Aerosol) 0.04 mg/ INH with the marketed QVARÂ® 40 mcg (Beclomethasone dipropionate hydrofluoroalkane (HFA)) and to demonstrate superiority of both active treatments over placebo.","primaryOutcome":{"measure":"Change in FEV1 From Pre Dose to End of Treatment","timeFrame":"4 weeks","effectByArm":[{"arm":"Group-I (Test)","deltaMin":0.23,"sd":0.01},{"arm":"Group-II (Reference)","deltaMin":0.22,"sd":0.01},{"arm":"Group-III (Placebo)","deltaMin":0.09,"sd":0.01}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["India"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":619},"commonTop":["Headache","Anaemia","Nausea","Pyrexia","Pain"]}}